Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:90110838
Filing Date:08/13/2020
NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular
application.
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
NeuroRx, Inc.
INTERNAL ADDRESS
Suite 200
*MAILING ADDRESS
913 North Market Street, Suite 200
*CITY
Wilmington
*STATE
(Required for U.S. applicants)
Delaware
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
19801
PHONE
202-340-1352
FAX
NA
*EMAIL ADDRESS
XXXX
WEBSITE ADDRESS
www.neurorxpharma.com
LEGAL ENTITY INFORMATION
*TYPE
CORPORATION
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary,
genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and
disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections
RLF-100 drug for treating COVID-19 as packaged for shipment
ADDITIONAL STATEMENTS INFORMATION
*TRANSLATION
(if applicable)
*TRANSLITERATION
(if applicable)
*CLAIMED PRIOR REGISTRATION
(if applicable)
*CONSENT (NAME/LIKENESS)
(if applicable)
*CONCURRENT USE CLAIM
(if applicable)
ATTORNEY INFORMATION
NAME
Brian Del Buono
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
NeuroRx, Inc.
STREET
7610 Maple Branch Rd , VA
CITY
Clifton
STATE
Virginia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
20124
PHONE
703-402-5866
EMAIL ADDRESS
bdelbuono@neurorxpharma.com
CORRESPONDENCE INFORMATION
NAME
Brian Del Buono
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
bdelbuono@neurorxpharma.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
jjavitt@neurorxpharma.com
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Plus
NUMBER OF CLASSES
1
APPLICATION FOR REGISTRATION PER CLASS
225
*TOTAL FEES DUE
225
*TOTAL FEES PAID
225
SIGNATURE INFORMATION
* SIGNATURE
/Jonathan C. Javitt, MD, MPH/
* SIGNATORY'S NAME
Jonathan C. Javitt, MD, MPH
* SIGNATORY'S POSITION
CEO
SIGNATORY'S PHONE NUMBER
202-340-1352
* DATE SIGNED
08/13/2020
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:90110838
Filing Date:08/13/2020
To the Commissioner for Trademarks:
MARK: RLF-100 (Standard Characters, see mark)
The literal element of the mark consists of RLF-100. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, NeuroRx, Inc., a corporation of Delaware, having an address of
Suite 200
913 North Market Street, Suite 200
Wilmington, Delaware 19801
United States
202-340-1352(phone)
NA(fax)
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual
dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders;
Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections
Use in Commerce: The applicant is using the mark in commerce on or in connection with the identified goods/services. The applicant attaches, or will later submit, one specimen as a JPG/PDF image file
showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, regardless of whether the mark itself is in the standard character format or is a
stylized or design mark. The specimen image file may be in color, and the image must be in color if color is being claimed as a feature of the mark.
In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee predecessor in interest at least as early as 03/01/2020, and first used in commerce
at least as early as 05/01/2020, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the
class of listed goods/services, consisting of a(n) RLF-100 drug for treating COVID-19 as packaged for shipment. Specimen File1
For informational purposes only, applicant's website address is: www.neurorxpharma.com
The owner's/holder's proposed attorney information: Brian Del Buono. Brian Del Buono of NeuroRx, Inc., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located
at
7610 Maple Branch Rd , VA
Clifton, Virginia 20124
United States
703-402-5866(phone)
bdelbuono@neurorxpharma.com
Brian Del Buono submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $225 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Jonathan C. Javitt, MD, MPH/ Date: 08/13/2020
Signatory's Name: Jonathan C. Javitt, MD, MPH
Signatory's Position: CEO
Signatory's Phone Number: 202-340-1352
Payment Sale Number: 90110838
Payment Accounting Date: 08/13/2020
Serial Number: 90110838
Internet Transmission Date: Thu Aug 13 01:53:08 ET 2020
TEAS Stamp: USPTO/FTK-XX.XXX.XXX.XX-2020081301530888
1857-90110838-74050fabd6b6bf86f3f7a62d0e
a66781e66ebd1522e27acacfc2c28dac06f14dd9
6-CC-53074974-20200813012403561011